Clinical Trial Update: Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen of total-body irradiation, busulfan, and interferon alfa before peripheral stem cell or bone marrow transplantat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• BUSULFAN (Busulfan)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED